Clonal reduction of CTL-P and acquired allograft tolerance in various human transplantation models.
Irschick
E
E
Division of Clinical Immunobiology, Department of Internal Medicine and Surgery, Innsbruck, Austria.
Hladik
F
F
Berger
M
M
Niederwieser
D
D
Herzog
W
W
Zanker
B
B
Kabelitz
D
D
Margreiter
K
K
Auböck
J
J
Miller
K
K
D016026:Bone Marrow Transplantation / Q000276:immunology; D016039:Corneal Transplantation / Q000276:immunology; D003524:Cyclosporins / Q000627:therapeutic use; D004817:Epidermis / Q000637:transplantation; D006801:Humans; D007108:Immune Tolerance; D016030:Kidney Transplantation / Q000276:immunology*; D016038:Skin Transplantation / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology*
D003524:Cyclosporins